Akers Biosciences and MyMD Pharmaceuticals Sign Definitive Merger Agreement

Author's Avatar
Nov 12, 2020
Article's Main Image

MyMD+Pharmaceuticals%2C+Inc. (“MyMD”) and Akers Biosciences, Inc. (“Akers”) (NASDAQ: AKER) today jointly announced that they have entered into a definitive merger agreement. Upon closing the transaction, the combined company is expected to be renamed MyMD Pharmaceuticals, Inc. and remain listed on the Nasdaq under the new ticker symbol “MYMD.”